KRASG12D, pulmonary LCH, and atorvastatin

被引：1
|
作者：
Aouba, Achille [1 ]
机构：
[1] Univ Caen Normandy, Caen, France
来源：
BLOOD | 2017年 / 130卷 / 04期
关键词：
LANGERHANS CELL HISTIOCYTOSIS; MUTATIONS;
D O I：
10.1182/blood-2017-06-788455
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In this issue of Blood, Kamata et al(1) elegantly demonstrate in mice that (1) KRAS(G12D) (but not BRAF(V600E)) mutation transfection in pulmonary myeloid cells induces an isolated pulmonary (IP)-Langerhans cell histiocytosis (LCH)-like neoplasm, via phosphatidylinositol 3-kinase (PI3K) activation, and that (2) atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A inhibitor that inhibits RAS interaction of PI3K, reduces tumor burden in vivo.
引用
收藏
页码：391 / 392
页数：4
相关论文
共 50 条
  • [21] NUDT7 Loss Promotes KrasG12D CRC Development
    Song, Jinsoo
    Park, Sujeong
    Oh, Jinjoo
    Kim, Deokha
    Ryu, Ji Hyun
    Park, Won Cheol
    Baek, In-Jeoung
    Cheng, Xi
    Lu, Xin
    Jin, Eun-Jung
    CANCERS, 2020, 12 (03)
  • [22] Discovery of Selective and Potent KRASG12D Inhibitors as Potential Therapy in Cancer
    Kargbo, Robert B.
    ACS MEDICINAL CHEMISTRY LETTERS, 2023,
  • [23] The Role Of Eosinophils In Krasg12d Induced Lung Tumor Initiation And Progression
    Li, F.
    Du, X.
    Zhang, C.
    Li, W.
    Chen, Z.
    Ying, S.
    Shen, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [24] KRASG12D GENE DOSAGE DRIVES PANCREATIC TUMOR EVOLUTION AND PROGRESSION
    不详
    CANCER DISCOVERY, 2018, 8 (03) : 265 - 265
  • [25] Differential Cell Susceptibilities to KrasG12D in the Setting of Obstructive Chronic Pancreatitis
    Shi, Chanjuan
    Pan, Fong Cheng
    Kim, Jessica N.
    Washington, M. Kay
    Padmanabhan, Chandrasekhar
    Meyer, Christian T.
    Kopp, Jane L.
    Sander, Maike
    Gannon, Maureen
    Beauchamp, R. Daniel
    Wright, Christopher, V
    Means, Anna L.
    CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2019, 8 (04): : 579 - 594
  • [26] 靶向KRASG12D抑制剂的研究现状
    陈晓睿
    毛国梁
    中南药学, 2023, 21 (06) : 1581 - 1588
  • [27] Differences in gynecologic tumor development in Amhr2-Cre mice with KRASG12D or KRASG12V mutations
    Kun, Eucharist H. S.
    Tsang, Yvonne T. M.
    Lin, Sophia
    Pan, Sophia
    Medapalli, Tejas
    Malpica, Anais
    Richards, JoAnne S.
    Gershenson, David M.
    Wong, Kwong-Kwok
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [28] Somatic activation of a conditional KrasG12D allele causes ineffective erythropoiesis in vivo
    Braun, Benjamin S.
    Archard, Joehleen A.
    Van Ziffle, Jessica A. G.
    Tuveson, David A.
    Jacks, Tyler E.
    Shannon, Kevin
    BLOOD, 2006, 108 (06) : 2041 - 2044
  • [29] Differences in gynecologic tumor development in Amhr2-Cre mice with KRASG12D or KRASG12V mutations
    Eucharist H. S. Kun
    Yvonne T. M. Tsang
    Sophia Lin
    Sophia Pan
    Tejas Medapalli
    Anais Malpica
    JoAnne S. Richards
    David M. Gershenson
    Kwong-Kwok Wong
    Scientific Reports, 10
  • [30] Discovery of Potent Deuterated Compounds as Potential KRASG12D Inhibitors in Cancer Therapy
    Kargbo, Robert B.
    ACS MEDICINAL CHEMISTRY LETTERS, 2023,
12345